Laurence H. Beck, MD, PhD

Associate Professor, Medicine

Laurence Beck
617.638.7330
650 Albany St Evans Biomed Research Ctr

Biography

Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.

Other Positions

  • Active Staff Privileges, Medicine, Boston Medical Center

Education

  • Harvard Medical School, MD
  • Harvard University, PhD
  • Princeton University, BA

Publications

  • Published on 4/10/2019

    Leon J, Pérez-Sáez MJ, Batal I, Beck LH, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV. Membranous Nephropathy Post-Transplantation: An Update of the Pathophysiology and Management. Transplantation. 2019 Apr 10. PMID: 30985736.

    Read at: PubMed
  • Published on 3/1/2019

    Zaghrini C, Seitz-Polski B, Justino J, Dolla G, Payré C, Jourde-Chiche N, Van de Logt AE, Booth C, Rigby E, Lonnbro-Widgren J, Nystrom J, Mariat C, Cui Z, Wetzels JFM, Ghiggeri G, Beck LH, Ronco P, Debiec H, Lambeau G. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Kidney Int. 2019 Mar; 95(3):666-679. PMID: 30784662.

    Read at: PubMed
  • Published on 1/25/2019

    Keri KC, Blumenthal S, Kulkarni V, Beck L, Chongkrairatanakul T. Primary membranous nephropathy: comprehensive review and historical perspective. Postgrad Med J. 2019 Jan; 95(1119):23-31. PMID: 30683678.

    Read at: PubMed
  • Published on 12/21/2018

    Stoddard SV, Welsh CL, Palopoli MM, Stoddard SD, Aramandla MP, Patel RM, Ma H, Beck LH. Structure and function insights garnered from in silico modeling of the thrombospondin type-1 domain-containing 7A antigen. Proteins. 2019 Feb; 87(2):136-145. PMID: 30520531.

    Read at: PubMed
  • Published on 11/1/2018

    Beck LH, Salant DJ. Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele. Kidney Int. 2018 11; 94(5):855-857. PMID: 30348302.

    Read at: PubMed
  • Published on 6/22/2018

    Luo W, Olaru F, Miner JH, Beck LH, van der Vlag J, Thurman JM, Borza DB. Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Front Immunol. 2018; 9:1433. PMID: 29988342.

    Read at: PubMed
  • Published on 3/15/2018

    Malatesta-Muncher R, Eldin KW, Beck LH, Michael M. Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol. 2018 Jun; 33(6):1089-1092. PMID: 29546599.

    Read at: PubMed
  • Published on 10/26/2017

    Larsen CP, Trivin-Avillach C, Coles P, Collins AB, Merchant M, Ma H, Wilkey DW, Ambruzs JM, Messias NC, Cossey LN, Rosales IA, Wooldridge T, Walker PD, Colvin RB, Klein J, Salant DJ, Beck LH. LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease. J Am Soc Nephrol. 2018 Feb; 29(2):644-653. PMID: 29074737.

    Read at: PubMed
  • Published on 8/19/2017

    Al-Rabadi L, Quillen K, Shashar M, Al Marji C, Jaberi A, Chitalia V, Henderson J, Salant D, Beck LH. Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy. Kidney Int Rep. 2018 Mar; 3(2):476-481. PMID: 29725652.

    Read at: PubMed
  • Published on 7/3/2017

    Beck LH. PLA2R and THSD7A: Disparate Paths to the Same Disease? J Am Soc Nephrol. 2017 Sep; 28(9):2579-2589. PMID: 28674044.

    Read at: PubMed

View 48 more publications: View full profile at BUMC

View all profiles